Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. (yeni pencere açar)

Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gülmezoglu AM.

Kaynak‎: J Matern Fetal Neonatal Med 2013;26(17):1705-9.

İndeks‎: PubMed 23574458

https://www.ncbi.nlm.nih.gov/pubmed/23574458 (yeni pencere açar)

Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. (yeni pencere açar)

Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I; Antifibrinolytic Trials Collaboration

Kaynak‎: Lancet 2018;391(10116):125-32.

İndeks‎: PubMed 29126600

DOI‎: 10.1016/S0140-6736(17)32455-8

https://www.ncbi.nlm.nih.gov/pubmed/29126600 (yeni pencere açar)

Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. (yeni pencere açar)

Gungorduk K, Asıcıoğlu O, Yıldırım G, Ark C, Tekirdağ Aİ, Besımoglu B.

Kaynak‎: Am J Perinatol 2013;30(5):407-13.

İndeks‎: PubMed 23023559

DOI‎: 10.1055/s-0032-1326986

https://www.ncbi.nlm.nih.gov/pubmed/23023559 (yeni pencere açar)

Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. (yeni pencere açar)

Gungorduk K, Yıldırım G, Asıcıoğlu O, Gungorduk OC, Sudolmus S, Ark C.

Kaynak‎: Am J Perinatol 2011;28(3):233-40.

İndeks‎: PubMed 20979013

https://www.ncbi.nlm.nih.gov/pubmed/20979013 (yeni pencere açar)

Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. (yeni pencere açar)

Shakur S, Roberts I, Fawole B, Chaudhri R, El-Sheikh M, et al.; WOMAN Trial Collaborators

Kaynak‎: Lancet 2017;389(10084):2105-16.

İndeks‎: PubMed 28456509

DOI‎: 10.1016/S0140-6736(17)30638-4

https://www.ncbi.nlm.nih.gov/pubmed/28456509 (yeni pencere açar)

Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials. (yeni pencere açar)

Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V.

Kaynak‎: Acta Obstet Gynecol Scand 2016;95(1):28-37.

İndeks‎: PubMed 26698831

DOI‎: 10.1111/aogs.12798

https://www.ncbi.nlm.nih.gov/pubmed/26698831 (yeni pencere açar)

Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery. (yeni pencere açar)

Sujata N, Tobin R, Kaur R, Aneja A, Khanna M, Hanjoora VM.

Kaynak‎: Int J Gynaecol Obstet 2016;133(3):312-5.

İndeks‎: PubMed 26952346

DOI‎: 10.1016/j.ijgo.2015.09.032

https://www.ncbi.nlm.nih.gov/pubmed/26952346 (yeni pencere açar)

Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. (yeni pencere açar)

Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, Ahonen J, Bremme K, Bødker B, Magnúsdóttir EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D, Gyte G.

Kaynak‎: Obstet Gynecol 2007;110(6):1270-8.

İndeks‎: PubMed 18055720

DOI‎: 10.1097/01.AOG.0000288515.48066.99

https://www.ncbi.nlm.nih.gov/pubmed/18055720 (yeni pencere açar)

The use of recombinant activated FVII in postpartum hemorrhage. (yeni pencere açar)

Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, Lippi G.

Kaynak‎: Clin Obstet Gynecol 2010;53(1):219-27.

İndeks‎: PubMed 20142658

DOI‎: 10.1097/GRF.0b013e3181cc4378

https://www.ncbi.nlm.nih.gov/pubmed/20142658 (yeni pencere açar)

Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. (yeni pencere açar)

Huber AW, Raio L, Alberio L, Ghezzi F, Surbek DV.

Kaynak‎: J Perinat Med 2011;40(1):43-9.

İndeks‎: PubMed 22017328

DOI‎: 10.1515/JPM.2011.109

https://www.ncbi.nlm.nih.gov/pubmed/22017328 (yeni pencere açar)

Postpartum hemorrhage: when uterotonics and sutures fail. (yeni pencere açar)

James AH, McLintock C, Lockhart E.

Kaynak‎: Am J Hematol 2012;87 Suppl 1:S16-22.

İndeks‎: PubMed 22430921

DOI‎: 10.1002/ajh.23156

https://www.ncbi.nlm.nih.gov/pubmed/22430921 (yeni pencere açar)

Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan. (yeni pencere açar)

Kobayashi T, Nakabayashi M, Yoshioka A, Maeda M, Ikenoue T.

Kaynak‎: Int J Hematol 2012;95(1):57-63.

İndeks‎: PubMed 22160834

DOI‎: 10.1007/s12185-011-0974-9

https://www.ncbi.nlm.nih.gov/pubmed/22160834 (yeni pencere açar)

Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. (yeni pencere açar)

Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, Ducloy-Bouthors AS, Mignon A, Raucoules M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Fabbro-Peray P, Gris JC.

Kaynak‎: J Thromb Haemost 2015;13(4):520-9.

İndeks‎: PubMed 25594352

DOI‎: 10.1111/jth.12844

https://www.ncbi.nlm.nih.gov/pubmed/25594352 (yeni pencere açar)

Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. (yeni pencere açar)

Lim Y, Loo CC, Chia V, Fun W.

Kaynak‎: Int J Gynaecol Obstet 2004;87(2):178-9.

İndeks‎: PubMed 15491576

DOI‎: 10.1016/j.ijgo.2004.08.007

https://www.ncbi.nlm.nih.gov/pubmed/15491576 (yeni pencere açar)

Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. (yeni pencere açar)

Moscardó F, Pérez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller S, Sanz MA.

Kaynak‎: Br J Haematol 2001;114(1):174-6.

İndeks‎: PubMed 11472364

https://www.ncbi.nlm.nih.gov/pubmed/11472364 (yeni pencere açar)

Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage. (yeni pencere açar)

Nohira T, Osakabe Y, Suda S, Takahashi C, Tanaka A, Ikeda K, Ikeda T, Okabe K.

Kaynak‎: J Obstet Gynaecol Res 2008;34(4 Pt 2):623-30.

İndeks‎: PubMed 18840167

https://www.ncbi.nlm.nih.gov/pubmed/18840167 (yeni pencere açar)

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (yeni pencere açar)

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

Kaynak‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

İndeks‎: PubMed 22489992

DOI‎: 10.1111/j.1399-6576.2012.02688.x

https://www.ncbi.nlm.nih.gov/pubmed/22489992 (yeni pencere açar)

Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. (yeni pencere açar)

Pepas LP, Arif-Adib M, Kadir RA.

Kaynak‎: Obstet Gynecol 2006;108(3 Pt 2):757-61.

İndeks‎: PubMed 17018493

DOI‎: 10.1097/01.AOG.0000197064.44340.d4

https://www.ncbi.nlm.nih.gov/pubmed/17018493 (yeni pencere açar)

Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. (yeni pencere açar)

Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA; Australian and New Zealand Haemostasis Registry.

Kaynak‎: Anesth Analg 2009;109(6):1908-15.

İndeks‎: PubMed 19923520

DOI‎: 10.1213/ANE.0b013e3181c039e6

https://www.ncbi.nlm.nih.gov/pubmed/19923520 (yeni pencere açar)

Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism. (yeni pencere açar)

Prosper SC, Goudge CS, Lupo VR.

Kaynak‎: Obstet Gynecol 2007;109(2 Pt2):524-5.

İndeks‎: PubMed 17267882

DOI‎: 10.1097/01.AOG.0000235711.11817.8c

https://www.ncbi.nlm.nih.gov/pubmed/17267882 (yeni pencere açar)

The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study. (yeni pencere açar)

Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R, Flynn CM, O'Riordan JM, Byrne BM.

Kaynak‎: Transfus Med 2012;22(5):344-9.

İndeks‎: PubMed 22994449

https://www.ncbi.nlm.nih.gov/pubmed/22994449 (yeni pencere açar)

The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. (yeni pencere açar)

Bell SF, Rayment R, Collins PW, Collis RE.

Kaynak‎: Int J Obstet Anesth 2010;19(2):218-23.

İndeks‎: PubMed 20194010

DOI‎: 10.1016/j.ijoa.2009.08.004

https://www.ncbi.nlm.nih.gov/pubmed/20194010 (yeni pencere açar)

Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. (yeni pencere açar)

Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C.

Kaynak‎: Br J Anaesth 2012;108(6):984-9.

İndeks‎: PubMed 22490316

DOI‎: 10.1093/bja/aes096

https://www.ncbi.nlm.nih.gov/pubmed/22490316 (yeni pencere açar)

Association between fibrinogen levels and severity of postpartum hemorrhage in singleton vaginal deliveries at a Japanese perinatal center. (yeni pencere açar)

Shibata Y, Shigemi D, Ito M, Terada K, Nakanishi K, Kato M, Igarashi M, Suzuki S.

Kaynak‎: J Nippon Med Sch 2014;81(2):94-6.

İndeks‎: PubMed 24805095

https://www.ncbi.nlm.nih.gov/pubmed/24805095 (yeni pencere açar)

A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. (yeni pencere açar)

Trigg DE, Stergiotou I, Peitsidis P, Kadir RA.

Kaynak‎: Haemophilia 2012;18(1):25-33.

İndeks‎: PubMed 21624012

DOI‎: 10.1111/j.1365-2516.2011.02573.x

https://www.ncbi.nlm.nih.gov/pubmed/21624012 (yeni pencere açar)

Tisseel for management of traumatic postpartum haemorrhage. (yeni pencere açar)

Dhulkotia JS, Alazzam M, Galimberti A.

Kaynak‎: Arch Gynecol Obstet 2009;279(3):437-9.

İndeks‎: PubMed 18985368

DOI‎: 10.1007/s00404-008-0824-z

https://www.ncbi.nlm.nih.gov/pubmed/18985368 (yeni pencere açar)

Use of FloSeal haemostatic gel in massive obstetric haemorrhage: a case report. (yeni pencere açar)

Moriarty KT, Premila S, Bulmer PJ.

Kaynak‎: BJOG 2008;115(6):793-5.

İndeks‎: PubMed 18355369

DOI‎: 10.1111/j.1471-0528.2007.01654.x

https://www.ncbi.nlm.nih.gov/pubmed/18355369 (yeni pencere açar)

Topical application of recombinant activated factor VII during cesarean delivery for placenta previa. (yeni pencere açar)

Schjoldager BTBG, Mikkelsen E, Lykke MR, Præst J, Hvas AM, Heslet L, Secher NJ, Salvig JD, Uldbjerg N

Kaynak‎: Am J Obstet Gynecol 2017;216(6):608.e1-5.

İndeks‎: PubMed 28219621

DOI‎: 10.1016/j.ajog.2017.02.024

https://www.ncbi.nlm.nih.gov/pubmed/28219621 (yeni pencere açar)

Fibrin sealant for management of complicated obstetric lacerations. (yeni pencere açar)

Whiteside JL, Asif RB, Novello RJ.

Kaynak‎: Obstet Gynecol 2010;115(2 Pt 2):403-4.

İndeks‎: PubMed 20093858

DOI‎: 10.1097/AOG.0b013e3181bb1e28

https://www.ncbi.nlm.nih.gov/pubmed/20093858 (yeni pencere açar)

Role of thromboelastography versus coagulation screen as a safety predictor in pre-eclampsia/eclampsia patients undergoing lower-segment caesarean section in regional anaesthesia. (yeni pencere açar)

Ahmad A, Kohli M, Malik A, Kohli M, Bogra J, Abbas H, Gupta R, Kushwaha BB.

Kaynak‎: J Obstet Gynaecol India 2016;66(Suppl 1):340-6.

İndeks‎: PubMed 27651627

https://www.ncbi.nlm.nih.gov/pubmed/27651627 (yeni pencere açar)

Assessment of coagulation in the obstetric population using ROTEM® thromboelastometry. (yeni pencere açar)

Armstrong S, Fernando R, Ashpole K, Simons R, Columb M.

Kaynak‎: Int J Obstet Anesth 2011;20(4):293-8.

İndeks‎: PubMed 21835606

https://www.ncbi.nlm.nih.gov/pubmed/21835606 (yeni pencere açar)

Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. (yeni pencere açar)

de Lange NM, Lancé MD, de Groot R, Beckers EA, Henskens YM, Scheepers HC.

Kaynak‎: Obstet Gynecol Surv 2012;67(7):426-35.

İndeks‎: PubMed 22926249

DOI‎: 10.1097/OGX.0b013e3182605861

https://www.ncbi.nlm.nih.gov/pubmed/22926249 (yeni pencere açar)

Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? (yeni pencere açar)

Karlsson O, Jeppsson A, Hellgren M.

Kaynak‎: Int J Obstet Anesth 2014;23(1):10-7.

İndeks‎: PubMed 24342222

https://www.ncbi.nlm.nih.gov/pubmed/24342222 (yeni pencere açar)

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. (yeni pencere açar)

Levy JH, Welsby I, Goodnough LT.

Kaynak‎: Transfusion 2014;54(5):1389-405.

İndeks‎: PubMed 24117955

DOI‎: 10.1111/trf.12431

https://www.ncbi.nlm.nih.gov/pubmed/24117955 (yeni pencere açar)

Coagulopathy and placental abruption: changing management with ROTEM-guided fibrinogen concentrate therapy. (yeni pencere açar)

McNamara H, Mallaiah S, Barclay P, Chevannes C, Bhalla A.

Kaynak‎: Int J Obstet Anesth 2015;24(2):174-9.

İndeks‎: PubMed 25659517

https://www.ncbi.nlm.nih.gov/pubmed/25659517 (yeni pencere açar)

Haemostatic monitoring during postpartum haemorrhage and implications for management. (yeni pencere açar)

Solomon C, Collis RE, Collins PW.

Kaynak‎: Br J Anaesth 2012;109(6):851-63.

İndeks‎: PubMed 23075633

DOI‎: 10.1093/bja/aes361

https://www.ncbi.nlm.nih.gov/pubmed/23075633 (yeni pencere açar)